Recent developments in the management of Huntington's disease.
Sign Up to like & getrecommendations! Published in 2022 at "Bioorganic chemistry"
DOI: 10.1016/j.bioorg.2022.105642
Abstract: Huntington's disease (HD) is a rare, incurable, inheritedneurodegenerative disorder manifested by chorea, hyperkinetic, and hypokinetic movements. The FDA has approved only two drugs, viz. tetrabenazine, and deutetrabenazine, to manage the chorea associated with HD. However,… read more here.
Keywords: huntington disease; recent developments; management huntington; huntington ... See more keywords
New developments in the management of vulvovaginal atrophy: a comprehensive overview
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2194017
Abstract: ABSTRACT Introduction Proper recognition and individualized therapy of vulvovaginal atrophy (VVA) is paramount. Areas covered Assessment of VVA should be performed using several questionnaires in combination with wet mount microscopy to determine Vaginal Cell Maturation… read more here.
Keywords: management vulvovaginal; new developments; microscopy; vulvovaginal atrophy ... See more keywords
Recent developments in the management of severe asthma
Sign Up to like & getrecommendations! Published in 2022 at "Breathe"
DOI: 10.1183/20734735.0178-2021
Abstract: Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation https://bit.ly/3KE1BH4 read more here.
Keywords: management severe; severe asthma; recent developments; developments management ... See more keywords
New developments in the management of Waldenström macroglobulinemia
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Management and Research"
DOI: 10.2147/cmar.s94059
Abstract: Waldenström macroglobulinemia (WM) is a rare, immunoglobulin M -associated lymphoplasmacytic lymphoma. With the recent discoveries of CXCR warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) and MYD88 mutations, our understanding of the biology of WM has expanded… read more here.
Keywords: waldenstr macroglobulinemia; new developments; developments management; management waldenstr ... See more keywords
Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
Sign Up to like & getrecommendations! Published in 2018 at "OncoTargets and therapy"
DOI: 10.2147/ott.s127609
Abstract: Lartruvo® (olaratumab) is a fully human immunoglobulin G subclass 1 (IgG1) monoclonal antibody that inhibits platelet-derived growth factor receptor alpha (PDGFRα). The antitumor activity of olaratumab has been tested in vitro and in vivo, and… read more here.
Keywords: management advanced; developments management; tissue sarcoma; advanced soft ... See more keywords